Clinical Trial Update: Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update presents results from a Phase 2 study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. The trial status was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-02-21